ArticlePLoS neglected tropical diseases2025
Hantavirus infections and small mammal diversity in Chile: No differences between protected and unprotected areas highlight the need for public health strategies.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Andes hantavirus in South America: Emerging epidemiological trends, regional challenges, and lessons beyond the MV Hondius outbreak.New microbes and new infections · 2026Article
- Orthohantavirus Infection Mimicking Acute Viral Hepatitis: An Underrecognized Clinical Presentation.Pathogens (Basel, Switzerland) · 2026Review
- Targeting Zoonotic Spillover Drivers for Global Pandemic Prevention: A Narrative Review.Microorganisms · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundZoonotic viruses, such as Orthohantavirus andesense (ANDV; the causative agent of hantavirus cardiopulmonary syndrome, HCPS), pose significant public health risks at the human-wildlife interface. Understanding their eco-epidemiological dynamics is critical for elucidating the interplay between reservoir hosts, environmental factors, and spillover to humans. In Chile, the long-tailed pygmy rice rat (Oligoryzomys longicaudatus) serves as the primary reservoir for ANDV. This study investigates whether protected areas (PA), which typically support higher biodiversity and stable ecosystems, exhibit lower ANDV seroprevalence compared to unprotected areas (UPA), where anthropogenic disturbances may alter host-pathogen dynamics. METHODOLOGY: Between 2001-2008, we conducted small mammal sampling across 22 sites (11 PA and 11 UPA) in natural landscapes of Chile. Seroprevalence of ANDV was assessed via strip immunoassay, while small mammal diversity was evaluated using standardized trapping protocols and diversity indices. We used similarity percentage analysis to identify species contributing to community dissimilarities and applied Renyi diversity profiles to compare small mammal diversity between area types. MAIN
findingsWe captured 627 small mammals (PA: 331, 14 species; UPA: 296, 10 species) across 12,898 trap-nights. Seroprevalence in O. longicaudatus was identical in PA and UPA (9.5%). No significant differences were found in the relative abundance or seropositivity of O. longicaudatus between area types. Ecological indices (Shannon-Wiener, Simpson, richness, evenness) and community composition (ANOSIM) also showed no significant differences. Rényi profiles indicated marginally higher diversity in PA, driven by greater richness and evenness.
conclusionsThese findings suggest that ecological factors, such as habitat type, climatic conditions, and/or human behavior, may play a more critical role in shaping viral prevalence than protection status alone. The study underscores the necessity for consistent public health interventions to mitigate the risk of hantavirus cardiopulmonary syndrome across all environments, particularly in regions where human activities intersect with natural habitats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.